Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.51 0.31 (0.48%) as of 4:30 Wed 5/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.89(B)
Last Volume: 7,231,910 Avg Vol: 8,754,576
52 Week Range: $65.27 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2493
  Page 5 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2023-02-15 4 A $56.38 $21,199 D/D 376 376     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-02-15 4 A $56.38 $21,199 D/D 376 83,114     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-02-06 4 D $86.36 $45,857 D/D (531) 105,242     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 1,817 105,773     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-02-06 4 D $86.36 $48,793 D/D (565) 32,010     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 1,864 32,575     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-01-24 4 D $84.02 $1,287,775 D/D (15,327) 103,956     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-01-24 4 A $0.00 $0 D/D 66,202 119,283     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-01-24 4 D $84.02 $104,521 D/D (1,244) 30,711     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-01-24 4 A $0.00 $0 D/D 5,884 31,955     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-01-24 4 D $84.02 $1,491,271 D/D (17,749) 82,738     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-01-24 4 A $0.00 $0 D/D 73,359 100,487     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-01-24 4 D $84.02 $4,963,734 D/D (59,078) 352,975     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-01-24 4 A $0.00 $0 D/D 215,017 412,053     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-01-24 4 D $84.02 $1,287,607 D/D (15,325) 76,365     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-01-24 4 A $0.00 $0 D/D 67,394 91,690     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-12-30 4 AS $85.33 $47,187 D/D (553) 45,556 -8%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-12-10 4 D $87.97 $13,108 D/D (149) 28,502     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-12-10 4 OE $0.00 $0 D/D 318 28,651     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-12-10 4 D $87.97 $135,650 D/D (1,542) 254,636     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-12-10 4 OE $0.00 $0 D/D 3,300 256,178     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-12-10 4 D $87.97 $42,753 D/D (486) 46,109     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-12-10 4 OE $0.00 $0 D/D 1,039 46,595     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-12-10 4 D $87.97 $42,226 D/D (480) 69,215     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-12-10 4 OE $0.00 $0 D/D 1,027 69,695     -
  2493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us